THAR NASDAQ
Tharimmune, Inc.
1W: -0.8%
1M: +6.3%
3M: +27.2%
YTD: +5.0%
1Y: +208.7%
3Y: -99.0%
$3.54
Last traded 2026-04-22 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$20M
-61.7% ▼
Net Income
-$36M
-194.5% ▼
EPS (Diluted)
$-1.12
+88.1% ▲
EBITDA
-$20M
-61.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $2M | $2M | $4M | $6M | $3M |
| SG&A Expenses | $1M | $5M | $6M | $6M | $17M |
| Operating Expenses | $3M | $7M | $9M | $12M | $20M |
| Operating Income | -$3M | -$7M | -$9M | -$12M | -$20M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $831K | $2M | $17K | $14K | -$28K |
| Income Before Tax | -$2M | -$8M | -$9M | -$12M | -$42M |
| Tax Expense | $0 | $0 | $0 | $0 | -$6M |
| Net Income | -$2M | -$8M | -$9M | -$12M | -$36M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-72.81 | $-280.77 | $-107.08 | $-9.41 | $-1.12 |
| EBITDA | -$1M | -$7M | -$9M | -$12M | -$20M |
| Shares Outstanding | 30305 | 30178 | 87029 | 1M | 32M |